74 - Squabbles Among Friends: Is It Necessary to Check HIV Viral Loads in PrEP Clinic? And Should Mothers With HIV Breast/Chest Feed?

Thursday, October 12, 2023

1:45 PM – 3:00 PM US ET

Location: 258 ABC

All relevant financial disclosures have been mitigated.

Moderator(s)

Colleen Kelley, MD, MPH (she/her/hers)

Associate Professor of Medicine
Emory University
Decatur, GA, United States

Debate Style Moderator(s)

Andres Camacho-Gonzalez, MD, MSc (he/him/his)

Associate Professor
Emory University Department of Pediatrics, Division of Infectious Diseases
Emory University School of Medicine/ Children's Healthcare of Atlanta
Atlanta, GA, United States
Gretchen Newman, MD (she/her/hers)

Assistant Professor
Wayne State University School of Medicine
Rochester Hills, MI, United States

Faculty(s)

Aniruddha Hazra, MD (he/him/his)

Assistant Professor of Medicine
University of Chicago
Chicago, IL, United States

Slides
Taimur Khan, MD MPH (he/him/his)

Clinician / Associate Medical Research Director
Fenway Health / The Fenway Institute
Boston, MA, United States

Slides
Allison Agwu, MD, MSc (she/her/hers)

Professor
Johns Hopkins University
Baltimore, MD, United States

Slides
Sharon Nachman, MD (she/her/hers)

Division Chief Pediatric Infectious Disease
Renaissance School of Medicine, SUNY Stony Brook
Stony Brook, NY, United States

Slides

Disclosure(s):

Colleen F. Kelley, MD, MPH: Gilead Sciences: Grant/Research Support (Ongoing); Humanigen: Grant/Research Support (Ongoing); Moderna, Inc.: Grant/Research Support (Ongoing); Novavax, Inc: Grant/Research Support (Ongoing); Viiv Healthcare: Grant/Research Support (Ongoing)

Andres Camacho-Gonzalez, MD, MSc: AbbVie, Angelini, Contrafect, Cubist, Genentech, Gilead Sciences, Jansen, Medtronic, MSD, Novartis, Pfizer, and ViiV Healthcare: Grant/Research Support (Ongoing); Merck and Company, Inc.: Grant/Research Support (Ongoing); ViiV Healthcare/GSK: Grant/Research Support (Ongoing)

Gretchen Newman, MD: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the pros and cons of checking viral load levels in PrEP clinics;
analyze the benefits of supporting parents with HIV in their infant feeding choices

Presentations:

1:45 PM – 2:03 PM US ET

The Future Is Here – HIV Screening in PrEP Clinics Needs a Facelift
Debate Style Speaker: Aniruddha Hazra, MD (he/him/his) – University of Chicago
2:03 PM – 2:21 PM US ET

Pros and Cons of Viral Load Monitoring During PrEP – CON
Debate Style Speaker: Taimur H. Khan, MD MPH (he/him/his) – Fenway Health / The Fenway Institute
2:21 PM – 2:39 PM US ET

Breast/Chest Feeding for Parents With HIV: Should We Support? – PRO
Debate Style Speaker: Allison Agwu, MD, MSc (she/her/hers) – Johns Hopkins University
2:39 PM – 2:57 PM US ET

Breast/Chest Feeding for Parents With HIV: Should We Support? – CON
Debate Style Speaker: Sharon Nachman, MD (she/her/hers) – Renaissance School of Medicine, SUNY Stony Brook